Date Filed | Type | Description |
04/21/2014 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 0% stake in Hi-Tech Pharmacal Co., Inc. |
04/17/2014 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
03/21/2014 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
03/20/2014 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 2.7% stake in Hi-Tech Pharmacal Co., Inc. |
03/13/2014 |
SC 13D
| GAMCO INVESTORS, INC. ET AL reports a 2.7% stake in Hi-Tech Pharmacal Co., Inc. |
03/12/2014 |
8-K
| Quarterly results |
03/11/2014 |
10-Q
| Quarterly Report for the period ended January 31, 2014 |
03/10/2014 |
SC 13G/A
| FMR LLC reports a 0.2% stake in HI-TECH PHARMACAL INC |
02/11/2014 |
SC 13G
| AQR CAPITAL MANAGEMENT LLC reports a 9.2% stake in Hi-Tech Pharmacal Co., Inc. |
02/10/2014 |
SC 13G/A
| AQR DELTA Master Acccount, L.P. reports a 5.4% stake in Hi-Tech Pharmacal Co., Inc. |
02/07/2014 |
SC 13G/A
| BlackRock Inc. reports a 12.5% stake in HI-TECH PHARMACAL CO INC |
01/31/2014 |
SC 13G/A
| BlackRock Inc. reports a 9.6% stake in HI-TECH PHARMACAL CO INC |
01/10/2014 |
SC 13G/A
| FMR LLC reports a 9.8% stake in HI-TECH PHARMACAL INC |
12/26/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
12/19/2013 |
8-K
| Submission of Matters to a Vote of Security Holders |
12/10/2013 |
8-K
| Quarterly results |
12/10/2013 |
10-Q
| Quarterly Report for the period ended October 31, 2013 |
11/26/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
11/07/2013 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
10/11/2013 |
8-K
| Other Events |
10/08/2013 |
SC 13G
| AQR DELTA Master Acccount, L.P. reports a 5.3% stake in Hi-Tech Pharmacal Co., Inc. |
09/16/2013 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
09/10/2013 |
8-K
| Quarterly results |
09/09/2013 |
10-Q
| Quarterly Report for the period ended July 31, 2013 |
09/06/2013 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
09/05/2013 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
08/27/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
08/27/2013 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other E...
Docs:
|
"Agreement and Plan of Merger, by and among Hi-Tech Pharmacal Co., Inc., Akorn, Inc. and Akorn Enterprises, Inc",
"Voting Agreement dated August 26, 2013, by and among Akorn Enterprises, Inc. and certain stockholders of Hi-Tech Pharmacal Co., Inc",
"Akorn to Acquire Hi-Tech Pharmacal for $640 Million" |
|
08/13/2013 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
07/11/2013 |
10-K
| Annual Report for the period ended April 30, 2013 |
05/28/2013 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
04/26/2013 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans |
03/13/2013 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
03/08/2013 |
8-K
| Quarterly results |
|